Abstract
This article reviews the role of inflammation in bladder dysfunction, and the potential for prostaglandins to play a contributing role. If this is the case, it presents this receptor system as a future therapeutic target, and also enhances our knowledge into the mechanisms underlying lower urinary tract function.
Copyright © Continence Foundation of Australia 2020
The final published version reprinted with permission from the publisher.
| Original language | English |
|---|---|
| Pages (from-to) | 58-60 |
| Number of pages | 3 |
| Journal | Australian and New Zealand Continence Journal |
| Volume | 26 |
| Issue number | 3 |
| Publication status | Published - 1 Sept 2020 |